Skip to main content

Analyzing the Growth and Expansion of the Neurostimulation Devices Market

The global healthcare economic burden, at present, is primarily characterized by major contributors such as chronic pain and neurological disorders. The annual societal cost for chronic pain and neurological disorders accounted for $635 billion and $789 billion respectively in the U.S., in 2014. Opioids are one of the most preferred medicines for the treatment of chronic pain, however, the side-effects associated with opioids have resulted in a decline in their overall usage and sale.
Consequently, the increasing cases of neurological disorders and the need for a novel approach for the treatment of such diseases has led to the advent of neuromodulation technologies. The rapid shift of the healthcare industry toward neurostimulation devices from opioids and other conventional treatment techniques can be attributed to the efficient, safe, and targeted approach of neurostimulation devices.



BIS Research recently published a market intelligence report titled “Global Neurostimulation Devices Market- Analysis and Forecast (2019-2024),” projecting the expected growth of the neurostimulation devices market across the globe during the forecast period, 2019-2024. As per the published report, the market is anticipated to witness a compound annual growth rate of 9.23% during the forecast period and is expected to reach $11.97 billion by 2024.  
Neurostimulation devices can be either implantable or non-implantable. The various implantable neurostimulation devices include spinal cord stimulation, auditory brainstem implant, vagus nerve stimulation, sacral nerve stimulation, hypoglossal nerve stimulation, and deep brain stimulation devices. Based on the analysis of the market by BIS Research, the spinal cord stimulation segment dominated the neurostimulation devices market by acquiring the largest market share in 2017. Moreover, the auditory brainstem implant segment is anticipated to lead the market in terms of growth rate during the forecast period.
Further, under the application segment, the global neurostimulation devices market includes pain management, hearing loss, epilepsy, depression, Parkinson’s disease, and urinary and fecal incontinence. Amongst these, hearing loss application segment is expected to grow at the fastest CAGR, during the forecast period.
Product launches, and mergers and acquisitions are the most adopted strategies by players in the global neurostimulation devices market. Other strategies include joint ventures, partnerships, and collaborations. Some of the leading players functioning in the market are Cochlear Ltd., Abbott Laboratories, Neuronetics Inc., Mainstay Medical International plc, Nexeon MedSystems Inc., and Helius Medical Technology.

Comments

Post a Comment

Popular posts from this blog

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...
Post a Comment
Read more

Strategies Incorporated to Sustain the Competition

  The strategies followed by various prominent companies to sustain the competition and expand their market share has been varying from mergers and acquisitions (M&A) to collaborations and partnerships. In the past three years (January 2017-September 2020), the market witnessed approximately eight M&A activities, seven partnerships, and alliances (collaborations, joint ventures, and other agreements), one business expansion, and four other developments. Among the different key developments, M&A activities constitute the dominant contributor’s strategies, followed by partnership and alliances. The global bioengineered skin substitutes market is dominated by juggernauts including AbbVie, Inc., Integra LifeSciences Corporation, Smith & Nephew plc, and Stryker Corporation, and other medium and small-medium enterprises that are offering wide ranges of bioengineered skin substitute products in the market. Several companies are attempting to enter the market and sustain...
Post a Comment
Read more

Increasing Adoption of Lidar in Construction Applications

  The construction industry is continuously growing and has been witnessing various technological innovations. The construction industry depicts high complexity, steep costs, and low toleration for error, that facilitate the adoption of laser scanning. Lidars have enabled the construction industry to gain 3D models of existing space and build digital plans on those real spaces. Digital collaboration frameworks such as building information modelling (BIM) deliver the value of the scans to every element of a construction team in formats that are best suited to their needs. BIM schematics also provide continuing value to facility maintenance and operation teams. BIS Research Report on Lidar Market Numerous stages of construction projects are scanned for quality assurance, cross-checking with models, and spotting errors. Lidars can also be deployed for quality evaluation of prefabricated materials, allowing an efficient, and cheap evaluation. Furthermore, lidars find applications i...
Post a Comment
Read more